1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. BIOGEN INC
Biogen Inc XNAS: BIIB

Biogen Inc Live Stock Price Today, Share Analysis and Chart

Strong Performer, Under Radar
about

Biogen and Idec merged in 2003, combining forces to market Biogen's multiple sclerosis drug Avonex and Idec's cancer drug Rituxan. Today, Rituxan and next-generation antibody Gazyva (oncology) and Ocrevus (multiple sclerosis) are marketed via a colla...

Read More
130.58 -0.94 (-0.71%)
40.49% Fall from 52W High
311.6K
XNAS Volume

XNAS 28 Jul, 2025 12:13 PM (EDT)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Biogen Inc is on 01 Aug 2025 for the purpose of Biogen Inc Second Quarter Earnings Results for 2025 See details
Durability score
High Financial Strength
66.7 / 100
Valuation Score
Affordable Valuation
55.5 / 100
Momentum Score
Technically Neutral
52.8 / 100
Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM
Analyst Price Target
169
1Yr Price target upside is 29%
30 analysts

10

S

8

W

0

O

3

T

SWOT Analysis

Biogen Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..